SPECIALE, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 1.201
Totale 1.201
Nazione #
IT - Italia 1.201
Totale 1.201
Città #
Genova 684
Rapallo 253
Genoa 241
Vado Ligure 18
Bordighera 5
Totale 1.201
Nome #
Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma 185
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation 114
Modulazione di CD44/xCT come possibile strategia per contrastare la resistenza all'Etoposide di cellule staminali del cancro 101
MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance 94
Glutathione and the switch of aerobic metabolism collaborate for multi-drug resistance of neuroblastoma 93
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide 86
Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809 83
Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma 63
CD44/xCT inhibition is a potential strategy to sensitize cancer stem cells to etoposide pro-oxidant effects 62
Pkcα inhibition as a strategy to sensitize neuroblastoma stem cells to etoposide by stimulating ferroptosis 62
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 50
“The Blinded Guardian”: clinical relevance of p53-null phenotype in high-grade serous ovarian cancers 49
xCT/CD44 modulation induces the sensitization of neuroblastoma-stem cells to etoposide. 46
Antitumor effects of PRIMA-1 and PRIMA-1met (APR246) in hematological malignancies: Still a mutant p53-dependent affair? 38
Evaluating the influence of a g-quadruplex prone sequence on the transactivation potential by wild-type and/or mutant p53 family proteins through a yeast-based functional assay 37
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? 34
Mutant p53K120R expression enables a partial capacity to modulate metabolism 29
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget) 16
MicroRNA-Mutant P53 Crosstalk in Chemoresistance: A Hint to Monitor Therapy Outcome 15
Totale 1.257
Categoria #
all - tutte 5.218
article - articoli 4.956
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020252 0 6 6 13 25 28 44 27 25 46 26 6
2020/2021141 3 9 17 8 9 11 9 19 11 13 23 9
2021/2022221 9 8 17 50 9 13 8 42 12 17 7 29
2022/2023317 20 40 2 47 29 47 0 22 44 2 55 9
2023/2024186 5 18 4 27 24 28 17 15 4 19 9 16
2024/202528 18 10 0 0 0 0 0 0 0 0 0 0
Totale 1.257